Cartoon illustration of Kodak’s pivot from cameras to pharmaceuticals: a film roll morphs into a pill bottle, while CEO Jim Continenza buys shares and a looming debt monster lurks nearby.

Eastman Kodak (KODK): Insider Buys, Debt Drama & a Pivot to Pills?!

Eastman Kodak insiders are snapping up shares, with CEO Jim Continenza leading the charge. But Kodak’s finances are shaky, its debt heavy, and its pivot to pharmaceuticals uncertain. High risk, high reward — or just a faded picture?

Read entire article